Ibogaine, rapid detox, ANR and medication treatment

People searching for ibogaine for opioid dependence are usually weighing it against three other things: sedation-assisted detox in the United States, a hospital procedure called ANR, and staying on buprenorphine or methadone. This page sets them side by side using what each program publishes.

Checked October 20, 2026. Sources at the end.

	Ibogaine programs	Sedation or anesthesia detox (US)	ANR (US hospital)	Buprenorphine, methadone, naltrexone
What it is	A single large oral dose of ibogaine (or root bark) that interrupts opioid withdrawal and produces a 24 to 36 hour psychoactive experience, usually with one or more boosters.	Opioid withdrawal run under sedation or general anesthesia with an opioid antagonist, over hours, inside a 3 to 4 day stay.	A hospital procedure under deep, monitored sedation of about 4 to 5 hours, followed by naltrexone tablets; the clinic describes it as treating the dependency rather than as a detox.	Daily buprenorphine (Suboxone), methadone from a clinic, or monthly naltrexone (Vivitrol), continued for months or years.
Where it is legal for a clinic to do it	Not in the United States (Schedule I). Mexico (unregulated), Costa Rica (unregulated but officially unauthorised), the Bahamas, Portugal, the Netherlands; prescription-only in Canada, New Zealand, Australia, South Africa, and in hospitals in Sao Paulo, Brazil.	United States: seven programs operate or appear to, in Michigan, California, Nevada, Illinois and Florida.	United States (Florida), plus Brazil and Georgia; the Israeli office sends patients to Tbilisi.	Everywhere in the United States; the standard of care.
Setting	Private clinics, staffed homes, villas and retreats; a few state a hospital agreement. No program on this site operates inside a hospital except Beneva in Sao Paulo.	Licensed clinics and an ambulatory surgery centre; one program inside a hospital.	Hospital ICU, as stated by the clinic.	Outpatient office or methadone clinic.
Who is in the room	From a cardiologist and emergency physician (Transcend, Ibogaine Treatment MX) to a nurse and paramedic (IbogaQuest) to facilitators only (ceremony retreats).	An anesthesiologist or addiction physician at most programs.	Board-certified anesthesiologists and critical care physicians with ICU nursing, as stated by the clinic.	A prescriber, with counselling.
Length	5 to 30 days on site; 21-day minimum for fentanyl users at Ambio; weeks of pre-treatment stabilisation for methadone or Suboxone patients.	3 to 4 days.	About 36 hours in hospital plus 2 to 3 follow-up days nearby.	Open-ended.
Published price	$2,200 to $6,600 for ceremony retreats; $7,500 to $13,500 for a medical clinic week; $12,000 to $36,000 with an opioid taper; luxury programs to $100,000 a month.	$6,700 to $21,500.	$21,500, paid in two parts.	Usually covered by insurance or Medicaid in the United States.
What the deaths look like	Cardiac. 19 to 48 deaths counted in the literature since 1990, almost all in opioid-dependent patients; press-documented deaths at three Mexican programs on this site and at retreats in Costa Rica.	Deaths and severe events were documented in the 1990s and 2000s, including a CDC report on a New York City program in 2012 that led to its closure.	The clinic's site claims an "exceptional long-term safety record" and publishes no death or complication count. No death, lawsuit or regulatory action involving the program was found in the sources checked.	Overdose deaths fall sharply while people stay on buprenorphine or methadone; the risk returns when they stop.
Evidence	Observational studies and case series, including a 2024 Stanford study of 30 veterans treated in Mexico; no completed randomised trial of ibogaine for opioid use disorder; FDA trials not yet started.	A 2005 randomised trial found no advantage over other detox methods and more serious adverse events (Collins and colleagues, JAMA, as cited in the CDC report).	The clinic cites its own follow-up data (a 91% long-term success rate, footnoted as follow-up on about 1,700 US patients one year after treatment; 25,000 patients worldwide) and two journal publications (2004 and 2023); no independent randomised trial.	The strongest evidence of any option for reducing overdose deaths, from large trials and cohort studies.
After the treatment	Boosters, integration coaching, microdosing at some programs; no medication. Withdrawal is interrupted; relapse is common without aftercare.	Oral naltrexone, Vivitrol or a naltrexone implant for 12 months at most programs.	Naltrexone tablets with the dose set at discharge, within a year-long follow-up plan.	The medication itself is the maintenance.
Who it tends to suit, as the programs describe it	People seeking a single intense reset, often with PTSD, TBI or alcohol as well as opioids; veterans; people who refuse maintenance medication. Not people with a heart condition or who will not come off methadone first.	People who want withdrawal over in days and will accept sedation; most programs require a medical screen.	People who want a hospital setting and a one-admission treatment; the clinic lists methadone and Suboxone dependence among the conditions it treats.	Anyone with opioid use disorder; recommended first-line by US guidelines.

What ibogaine does that the others do not

Ibogaine is the only option on the table that is also used for PTSD, TBI, alcohol and stimulant dependence, and the only one that produces a psychoactive experience many patients describe as the point. It is also the only one that is illegal in the United States and the only one with a cardiac death rate measured in the published literature. If what you want is the experience, or you are a veteran with TBI symptoms, the other three options are not substitutes. If what you want is to stop being physically dependent on opioids, they are.

What the US options do that ibogaine does not

They happen at home, legally, with a US physician who can be held to account, in or next to a hospital. Sedation detox takes 3 to 4 days and ends with naltrexone. ANR is a single hospital admission of about 36 hours under sedation in an ICU, followed by naltrexone tablets; the clinic lists methadone and Suboxone dependence among what it treats and publishes no weeks-long switch requirement, the step that makes ibogaine programs long and, when skipped, dangerous. Medication treatment has the strongest evidence for keeping people alive, and it is what most US physicians will recommend first; the people searching for ibogaine are often the ones who have decided they do not want to stay on it.

Where to look next

Ibogaine programs: all programs, with filters for physician presence and cardiac screening, and the safety record.
Sedation and anesthesia detox programs in the United States: the directory at sedationdetox.com lists the seven programs with setting, physician, price and public record.
ANR: the ANR Clinic profile on this site, compiled from the clinic's site and directories, and the clinic's own comparison with rapid detox.
Medication treatment: the National Institute on Drug Abuse research report on medications for opioid use disorder, and findtreatment.gov for providers.

Sources

Ibogaine program facts: each profile on this site, with its sources.
Arns, Shinozuka, Barsuglia, preprint, June 2026 (clinic death rates)
Stanford Medicine, January 2024 (veterans study)
sedationdetox.com: US sedation and anesthesia detox programs
CDC MMWR, September 2013: deaths and severe adverse events associated with anesthesia-assisted rapid opioid detoxification, New York City, 2012
ANR Clinic treatment page and ANR vs rapid detox
NIDA: Medications to treat opioid use disorder

Statements about safety, outcomes and patient numbers are each program's own and are reported as such. Not medical advice.